- MKM likes the odds of Auxilium Pharmaceuticals (NASDAQ:AUXL) winning a PD indication for Xiaflex come the December 6 PDUFA date.
- Analyst Jon LeCroy cites six poster presentations as supportive of approval.
- Buy rating reiterated.
- Price target is $24.
- More on the PDUFA date here.
MKM sees PD approval for Xiaflex next month
Recommended For You
More Trending News
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| AUXL | - | - |
| Auxilium Pharmaceuticals, Inc. | ||